DCGI

Experts Question The Emergency Use Authorization Given To Bharat Biotech And Astrazeneca

As the Covid-vaccines –one, jointly produced by UK-Swedish biopharmaceutical company AstraZeneca and Oxford University and another by the Bharat Biotech — got emergency use approval, many experts have questioned the very basis on these vaccines got the go ahead signal from the government. They also questioned why other candidates such as Sputnik V and Pfizer …

Experts Question The Emergency Use Authorization Given To Bharat Biotech And Astrazeneca Read More »

‘No Corona, Corona No’: Ramdas Athawale Coins New Slogan For Coronavirus Strain

Union Minister Ramdas Athawale on Sunday gave a new slogan to combat the new strain of coronavirus, “No corona, corona no”. “Earlier I gave the slogan ‘Go Corona, Corona Go’ and now corona is going. For the new coronavirus strain, I give the slogan of ‘No Corona, Corona No,” the Republican Party of India (RPI) …

‘No Corona, Corona No’: Ramdas Athawale Coins New Slogan For Coronavirus Strain Read More »

India All Set To Roll Out COVID-19 Vaccination Programme, Dry Run To Be Conducted In 4 States

India is gearing up with  “realistic” roadmap of Covid-19 vaccine distribution as the government is set to begin a dry run of its vaccination drive. The Centre has chosen Punjab to conduct a dry run of COVID-19 vaccine on December 28 and 29, state Health Minister Balbir Singh Sidhu said on Thursday. “The districts of …

India All Set To Roll Out COVID-19 Vaccination Programme, Dry Run To Be Conducted In 4 States Read More »

COVAXIN Likely To Be Available For Public Use By February End

COVAXIN, the Covid vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by the end of February 2021, said Dr. Sanjay Roy, principal investigator (PI) heading its clinical trial at AIIMS. “We …

COVAXIN Likely To Be Available For Public Use By February End Read More »

Here’s What You Need To Know About Emergency Use Authorisation Firms Are Seeking For Covid-19 Vaccines

On Sunday, The Serum Institute of India (SII) became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorization (EUA) for the Oxford Covid-19 vaccine in the country, official sources said. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorization for the first …

Here’s What You Need To Know About Emergency Use Authorisation Firms Are Seeking For Covid-19 Vaccines Read More »

A Day After Pfizer, India’s Serum Institute Seeks Emergency Use Nod For Covishield

The Serum Institute of India (SII) on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorization for the Oxford Covid-19 vaccine in the country, citing unmet medical needs due to the pandemic and in the interest of the public at large, official sources said. …

A Day After Pfizer, India’s Serum Institute Seeks Emergency Use Nod For Covishield Read More »

When Will Pfizer’s Covid Vaccine Be Available In India?

Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorization for its Covid-19 vaccine in the country after its parent company secured such clearance in the UK and Bahrain. The firm, in its application submitted to the drug regulator, has sought permission to …

When Will Pfizer’s Covid Vaccine Be Available In India? Read More »